D. Vrbanec

1.2k total citations
24 papers, 575 citations indexed

About

D. Vrbanec is a scholar working on Oncology, Astronomy and Astrophysics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Vrbanec has authored 24 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Astronomy and Astrophysics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Vrbanec's work include Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Solar and Space Plasma Dynamics (5 papers). D. Vrbanec is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Solar and Space Plasma Dynamics (5 papers). D. Vrbanec collaborates with scholars based in Croatia, Austria and Germany. D. Vrbanec's co-authors include B. Vršnak, T. Žic, Christian Möstl, Jaša Čalogović, Yong‐Jae Moon, A. Shanmugaraju, Manuela Temmer, Mateja Dumbović, S. Lulić and Astrid Veronig and has published in prestigious journals such as Journal of Clinical Oncology, Monthly Notices of the Royal Astronomical Society and British Journal of Cancer.

In The Last Decade

D. Vrbanec

24 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Vrbanec Croatia 11 360 138 123 58 45 24 575
Masaki Morimoto Japan 13 99 0.3× 85 0.6× 159 1.3× 102 1.8× 60 1.3× 82 576
Xiaoyu Lai China 20 230 0.6× 297 2.2× 172 1.4× 45 0.8× 73 1.6× 124 1.3k
Dave Carter United States 12 289 0.8× 97 0.7× 35 0.3× 85 1.5× 47 1.0× 27 692
Hao Ning China 14 117 0.3× 248 1.8× 62 0.5× 70 1.2× 131 2.9× 50 534
G. Mariatos Greece 13 193 0.5× 137 1.0× 107 0.9× 42 0.7× 27 0.6× 25 428
S. Shulman United States 11 138 0.4× 359 2.6× 102 0.8× 74 1.3× 283 6.3× 27 741
T. Sakai Japan 12 111 0.3× 33 0.2× 31 0.3× 140 2.4× 16 0.4× 63 364
M. Oda Japan 14 46 0.1× 266 1.9× 224 1.8× 231 4.0× 91 2.0× 51 816

Countries citing papers authored by D. Vrbanec

Since Specialization
Citations

This map shows the geographic impact of D. Vrbanec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Vrbanec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Vrbanec more than expected).

Fields of papers citing papers by D. Vrbanec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Vrbanec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Vrbanec. The network helps show where D. Vrbanec may publish in the future.

Co-authorship network of co-authors of D. Vrbanec

This figure shows the co-authorship network connecting the top 25 collaborators of D. Vrbanec. A scholar is included among the top collaborators of D. Vrbanec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Vrbanec. D. Vrbanec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vrbanec, D., B. Ciardi, Vibor Jelić, et al.. (2020). Predictions for the 21cm-galaxy cross-power spectrum observable with SKA and future galaxy surveys. Monthly Notices of the Royal Astronomical Society. 12 indexed citations
2.
Vrbanec, D., B. Ciardi, Vibor Jelić, et al.. (2016). Predictions for the 21 cm-galaxy cross-power spectrum observable with LOFAR and Subaru. Monthly Notices of the Royal Astronomical Society. 457(1). 666–675. 25 indexed citations
3.
Brodowicz, Thomas, István Láng, Zsuzsanna Kahán, et al.. (2014). Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses. British Journal of Cancer. 111(11). 2051–2057. 24 indexed citations
4.
Brodowicz, Thomas, Tudor–Eliade Ciuleanu, Davorin Radosavljević, et al.. (2013). FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study. Annals of Oncology. 24(7). 1769–1777. 51 indexed citations
5.
Knežević, Jelena, et al.. (2012). Single Nucleotide Polymorphism in the Interleukin 12B Gene is Associated with Risk for Breast Cancer Development. Scandinavian Journal of Immunology. 76(3). 329–335. 26 indexed citations
6.
Vršnak, B., T. Žic, D. Vrbanec, et al.. (2012). Propagation of Interplanetary Coronal Mass Ejections: The Drag-Based Model. Solar Physics. 285(1-2). 295–315. 210 indexed citations
7.
Petričević, Branka, et al.. (2011). Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer. Medical Oncology. 29(2). 486–494. 23 indexed citations
8.
Ciuleanu, Tudor–Eliade, Einat Shmueli, D. Vrbanec, et al.. (2011). Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 29(15_suppl). 3580–3580. 5 indexed citations
9.
Vršnak, B., et al.. (2010). The role of aerodynamic drag in propagation of interplanetary coronal mass ejections. Astronomy and Astrophysics. 512. A43–A43. 83 indexed citations
10.
Sirotković-Skerlev, Maja, et al.. (2009). Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients. Medical Oncology. 27(3). 887–893. 21 indexed citations
11.
Shanmugaraju, A., Yong‐Jae Moon, B. Vršnak, & D. Vrbanec. (2009). Radial Evolution of Well-Observed Slow CMEs in the Distance Range 2 – 30 R ⊙. Solar Physics. 257(2). 351–361. 6 indexed citations
12.
13.
Vrbanec, D., et al.. (2009). [Hormonal therapy with aromatase inhibitor in advanced breast cancer].. PubMed. 120(10-11). 315–8. 1 indexed citations
14.
Vršnak, B., D. Vrbanec, & Jaša Čalogović. (2008). Dynamics of coronal mass ejections. Astronomy and Astrophysics. 490(2). 811–815. 26 indexed citations
15.
Ciuleanu, Tudor–Eliade, G. Kurteva, Janja Ocvirk, et al.. (2008). A randomized, open-label CECOG phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 26(15_suppl). 4032–4032. 9 indexed citations
16.
Vršnak, B., D. Vrbanec, Jaša Čalogović, & T. Žic. (2008). The role of aerodynamic drag in dynamics of coronal mass ejections. Proceedings of the International Astronomical Union. 4(S257). 271–277. 4 indexed citations
17.
Sučić, Mirna, et al.. (2003). Expression of cyclooxygenase-2 in fine-needle aspirates from breast carcinoma and benign breast diseases. The Breast. 12(1). 51–57. 7 indexed citations
18.
Levanat, Sonja, et al.. (1991). The role of insulin-related substance in Hodgkin's disease. Journal of Cancer Research and Clinical Oncology. 117(6). 615–619. 3 indexed citations
19.
Spaventi, S & D. Vrbanec. (1987). Effect of calcitonin on the skeleton and bone pain in patients with osteolytic metastases.. PubMed. 41(1). 33–42. 3 indexed citations
20.
Pavelić, Krešimir, et al.. (1987). Autocrine tumour growth regulation by somatomedin C: An in — vitro model. Journal of Steroid Biochemistry. 28. 93–93. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaki Morimoto Breakdown of academic impact, for papers by Xiaoyu Lai Breakdown of academic impact, for papers by Dave Carter Breakdown of academic impact, for papers by Hao Ning Breakdown of academic impact, for papers by G. Mariatos Breakdown of academic impact, for papers by S. Shulman Breakdown of academic impact, for papers by T. Sakai Breakdown of academic impact, for papers by M. Oda
Rankless by CCL
2026